Recent Updates
Recently added Catalysts
EBS Positive Sentiment Score: 70/100

Emergent BioSolutions to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024

Key Takeaway: Emergent BioSolutions, a global leader in public health solutions, has announced that its Interim CEO and CFO will present at the 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024. The presentation will include a live audio link and slides available on the company's investor section post-event. This participation reflects the company's commitment to public health and investor engagement.

Market Sentiment Analysis

POSITIVE FACTORS

  • Emergent BioSolutions will present at the prestigious J.P. Morgan Healthcare Conference.
  • The conference is an opportunity to showcase their solutions addressing public health threats.
  • The company is actively engaging with investors through this high-profile event.

Full Press Release Details

GAITHERSBURG, Md., Jan. 09, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS), a global company providing solutions that address public health threats and brings lifesaving, life-extending products to market, today announced that Haywood Miller, Interim Chief Executive Officer and Rich Lindahl, Chief Financial Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Thursday, January 11, 2024, at 9:00 a.m. PT.
The audio link for Emergent's session may be accessed here, and will be live for up to 30 days.
The company’s slides will be made available at the time of the presentation on the Investors section of the Emergent website.
About Emergent BioSolutions
Safe Harbor Statement
This communication, and the presentation to which it relates, include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, are forward-looking statements. We generally identify forward-looking statements by using words like “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “forecast,” “future,” “goal,” “intend,” “may,” “plan,” “position,” “possible,” “potential,” “predict,” “project,” “should,” “target,” “will,” “would,” and similar expressions or variations thereof, or the negative thereof, but these terms are not the exclusive means of identifying such statements. Forward-looking statements are based on our current intentions, beliefs and expectations regarding future events based on information that is currently available. We cannot guarantee that any forward-looking statement will be accurate. Readers should realize that if underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could differ materially from our expectations. Readers are, therefore, cautioned not to place undue reliance on any forward-looking statements. Any forward-looking statement speaks only as of the date of this communication and, except as required by law, we do not undertake any obligation to update any forward-looking statement to reflect new information, events or circumstances.
There are a number of important factors that could cause our actual results to differ materially from those indicated by any forward-looking statements. Readers should consider this cautionary statement, as well as the risk factors and other disclosures included in our periodic reports filed with the Securities and Exchange Commission, when evaluating our forward-looking statements.
Executive Vice President, CFO
Vice President, Communications

Frequently Asked Questions

When will Emergent BioSolutions present at the J.P. Morgan Conference?

Emergent BioSolutions will present on January 11, 2024, at 9:00 a.m. PT.

Who will represent Emergent at the conference?

Haywood Miller, Interim CEO, and Rich Lindahl, CFO, will present.

Where can I access Emergent's presentation slides?

The slides will be available in the Investors section of Emergent's website.

How long will the audio of the presentation be available?

The audio link will be live for up to 30 days following the presentation.

What is the nature of Emergent's forward-looking statements?

These statements reflect current beliefs and expectations, and may change.

Last updated: Jan 9, 2024